12:37 PM
 | 
Apr 20, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Tmunity adds $35M to series A round

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised an additional $35 million for its series A round from Kleiner Perkins and affiliates, bringing the round's total to $135 million. In...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >